Literature DB >> 6735253

Measurement of intestinal progression of a meal and its residues in normal subjects and patients with functional diarrhoea by a dual isotope technique.

R Jian, Y Najean, J J Bernier.   

Abstract

A new double isotopic method was used to measure the gastrointestinal progression of a meal in nine healthy subjects and seven patients with functional diarrhoea. 51 Chromium chloride (colonic marker) was ingested eight hours before the beginning of the scintigraphic study so that it was by then located in the colon at that time. A second marker, 99m Technetium sulphur colloid labelled the meal. Scintigraphic images were taken before and after the meal for two hours, detecting simultaneously the two isotopes. In the 51 Cr window right colon was localised and intracolonic propulsion was studied; and in the 99m Tc window gastric emptying and colon filling of the meal marker was quantified. A propulsive gastrocolic reflex was evidenced in five of the seven patients with functional diarrhoea but in none of the normal subjects. Unabsorbed residues of the meal are propelled rapidly in the ileocaecal region. Small intestinal transit of the meal marker was twice as rapid in patients with functional diarrhoea as in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6735253      PMCID: PMC1432602          DOI: 10.1136/gut.25.7.728

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Differential measurement of small and large bowel transit times in constipation and diarrhoea: A new approach.

Authors:  S L Waller
Journal:  Gut       Date:  1975-05       Impact factor: 23.059

2.  [Twenty four-hour intestinal water and electrolyte flow rates in normal man: assessment by the slow marker perfusion technique (author's transl)].

Authors:  P Emonts; N Vidon; J J Bernier; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1979-02

3.  [Study of the intestinal transit time by the Cl3 51Cr dilution curve. Comparison with the carmine test].

Authors:  J J Bernier
Journal:  Biol Gastroenterol (Paris)       Date:  1969

4.  [Study of the progression of an ordinary meal in the human small bowel by a scintigraphic method (author's transl)].

Authors:  R Jian; A Pecking; Y Najean; J J Bernier
Journal:  Gastroenterol Clin Biol       Date:  1979-10

5.  Effect of eating and gastrointestinal hormones on human colonic myoelectrical and motor activity.

Authors:  W J Snape; S A Matarazzo; S Cohen
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

6.  Inhibitory role of the distal small intestine on the gastric secretory response to meals in man.

Authors:  J E Clain; V L Go; J R Malagelada
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

7.  Measurement of the mean transit time of dietary residue through the human gut.

Authors:  J H Cummings; D J Jenkins; H S Wiggins
Journal:  Gut       Date:  1976-03       Impact factor: 23.059

8.  Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements.

Authors:  J H Bond; M D Levitt; R Prentiss
Journal:  J Lab Clin Med       Date:  1975-04

9.  Propulsion (mass movements) in the human colon and its relationship to meals and somatic activity.

Authors:  D J Holdstock; J J Misiewicz; T Smith; E N Rowlands
Journal:  Gut       Date:  1970-02       Impact factor: 23.059

10.  Location of the site of bacterial bile-salt deconjugation by combining abdominal scintigraphy with expired C-14.

Authors:  B I Hirshowitz; R Beschi; H Bondi; J Goel; W N Tauxe
Journal:  J Nucl Med       Date:  1977-06       Impact factor: 10.057

View more
  15 in total

Review 1.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 2.  Orocaecal transit time in health and disease.

Authors:  I T Gilmore
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

3.  Colonic myoelectrical activity in IBS painless diarrhoea.

Authors:  J Frexinos; J Fioramonti; L Bueno
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

4.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

5.  Proximal colonic response and gastrointestinal transit after high and low fat meals.

Authors:  K P Steed; E K Bohemen; G M Lamont; D F Evans; C G Wilson; R C Spiller
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

Review 6.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 2. Motility of the small bowel, esophagus, stomach, and gall-bladder.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

7.  The effect of adrenoceptor antagonists on the ileal brake mechanism in the rat.

Authors:  N J Brown; R D Rumsey; C Bogentoft; N W Read
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

Review 8.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Determinants of accelerated small intestinal transit in alcohol-related chronic pancreatitis.

Authors:  Lucilene Rosa-E-Silva; Luiz E A Troncon; Lourenço Gallo; Milton C Foss; Afonso D C Passos; Gleici C Perdoná; Jorge A Achcar; Ricardo B Oliveira
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

10.  Scintigraphic measurement of ileocaecal transit in irritable bowel syndrome and chronic idiopathic constipation.

Authors:  R Hutchinson; A Notghi; N B Smith; L K Harding; D Kumar
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.